Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
6.02
-0.35 (-5.42%)
At close: Sep 12, 2025, 4:00 PM EDT
5.95
-0.07 (-1.16%)
After-hours: Sep 12, 2025, 7:46 PM EDT
Company Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.
Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial.
The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Bio Green Med Solution, Inc.
| Country | Malaysia |
| Founded | 1996 |
| Employees | 12 |
| CEO | Sing Wong |
Contact Details
Address: Level 10, Tower 11 Kuala Lumpur, 592000 Malaysia | |
| Phone | 60 9 08517 7330 |
| Website | cyclacel.com |
Stock Details
| Ticker Symbol | BGMS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
Key Executives
| Name | Position |
|---|---|
| Sing Wong | Chief Executive Officer |
| Cu Kiu | Chief Financial Officer |